High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234

N. J. Vogelzang, J. E. Herndon, A. Miller, G. Strauss, G. Clamon, F. M. Stewart, J. Aisner, A. Lyss, M. R. Cooper, Y. Suzuki, M. R. Green

    Research output: Contribution to journalArticlepeer-review

    38 Scopus citations

    Fingerprint

    Dive into the research topics of 'High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234'. Together they form a unique fingerprint.

    Medicine & Life Sciences